Environmental, health and safety guidelines and biopharma outsourcing: an Indian perspective
Abstract:
Biopharma outsourcing to India is growing by leaps and bounds. This chapter discusses the industry’s preparedness from an environment, health, and safety perspective. Foreign entities are coming under closer scrutiny as to whether the products which are manufactured by their overseas partners and subsidiaries are in conformity with environmental, health and safety guidelines. The guidelines are also discussed in detail and their applicability in the Indian scenario is analysed.
Keywords
environmental
health and safety (EHS)
evaluation
quality
compliance
audit
standards
requirements
environment management systems
facilities
challenges
Get Outsourcing Biopharma R&D to India now with the O’Reilly learning platform.
O’Reilly members experience books, live events, courses curated by job role, and more from O’Reilly and nearly 200 top publishers.
